Scientific Advisory Board

To assist in our pursuit of promising new research directions, we have assembled an international group of preeminent researchers of bipolar disorder. This group, called the Scientific Advisory Board, meets regularly to lend expertise and a diverse set of perspectives in support of our mission of developing innovative treatments for bipolar disorder.

Ana Andreazza, PhD

Ana Andreazza, PhD

Ana Andreazza, PhD, is an Associate Professor at Department of Pharmacology & Toxicology at the University of Toronto, holding a Tier II Canada Research Chair in Molecular Pharmacology of Mood Disorders. Dr. Andreazza is cross-appointed as Scientist at Centre for Addiction and Mental Health in Toronto, Canada and an Associate Professor at Department of Psychiatry at the University of Toronto.  |  read more...

Gabriela Apiou, PhD

Gabriela Apiou, PhD

Gabriela Apiou, PhD, is an Assistant Professor at Harvard Medical School. She received her PhD degree in Biomedical Engineering from Ecole Nationale Supérieure des Arts et Métiers Angers, France in 1998 and her Habilitation à Diriger des Recherches in Health and Life Sciences from University Paris Est Créteil, France in 2010.  |  read more...

Michael Berk, PhD

Michael Berk, PhD

Michael Berk, PhD, is currently a NHMRC Senior Principal research Fellow, and is Alfred Deakin Chair of Psychiatry at Deakin University and Barwon Health, where he heads the IMPACT Strategic Research Centre.  |  read more...

Randy Buckner, PhD

Randy Buckner, PhD

Randy Buckner, PhD, is Professor of Psychology and of Neuroscience at Harvard University and affiliated with the Center for Brain Science. He is also Professor at the Harvard Medical School and the Director for Psychiatric Neuroimaging Research at the Massachusetts General Hospital.  |  read more...

Mark Fishman, MD

Mark Fishman, MD

Mark Fishman, MD, is Professor in the Harvard Department of Stem Cell and Regenerative Biology and Chief of the Pathways Clinical Service at the MGH for patients with complex medical disorders. His current research focus is on the genes that guide social behavior, using genetics of the zebrafish.  |  read more...

Mason Freeman, MD

Mason Freeman, MD

Mason W. Freeman, MD, graduated from Harvard College and received his M.D. at the University of California, San Francisco. He served as an intern, resident, endocrinology fellow, and Chief Resident in Medicine in the Department of Medicine at the Massachusetts General Hospital.  |  read more...

Sophia Frangou, MD, PhD

Sophia Frangou, MD, PhD

Sophia Frangou, MD, PhD, is Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai, New York. She trained in Psychiatry at the Maudsley Hospital, London and in parallel she and obtained her Master’s Degree and her PhD in Neuroscience from the University of London.  |  read more...

John Geddes, MD

John Geddes, MD

John Geddes, MD, is Head of the Department of Psychiatry at Oxford University, Director of R&D at Oxford Health NHS Foundation Trust (OH), Director of the NIHR Oxford Cognitive Health Research Facility and Director of the NIHR Oxford Health Bioeedical Research Centre.  |  read more...

Felice Jacka, PhD

Felice Jacka, PhD

Felice Jacka, PhD, is an NHMRC Career Development Fellow at Deakin University where she is director of the Food and Mood Centre. She is president of the International Society for Nutritional Psychiatry Research (ISNPR) and the Australian Alliance for the Prevention of Mental Disorders (APMD).  |  read more...

D, PhD

Dost Öngür, MD, PhD

Dost Öngür, MD, PhD, completed medical school and his doctoral training at Washington University in St. Louis in 2000 and completed his psychiatric residency training at the MGH/McLean Adult Psychiatry program. He is currently the Chief of the Psychotic Disorders Division, responsible for all clinical services serving patients with psychotic disorders including a first episode psychosis subspecialty program.  |  read more...

Jerrold Rosenbaum, MD

Jerrold Rosenbaum, MD

Jerrold Rosenbaum, MD, is the psychiatrist-in-chief at the Massachusetts General Hospital and Stanley Cobb Professor of Psychiatry at Harvard Medical School. Dr. Rosenbaum is recognized as one of the world’s authorities on mood and anxiety disorders, with a special emphasis on pharmacotherapy of those conditions.  |  read more...

Jordan Smoller, MD, ScD

Jordan Smoller, MD, ScD

Jordan Smoller, MD, ScD, is the MGH Trustees Endowed Chair in Psychiatric Neuroscience, Professor of Psychiatry at Harvard Medical School and Professor in the Department of Epidemiology at the Harvard School of Public Health in Boston.  |  read more...

Lakshmi Yatham, MD

Lakshmi Yatham, MD

Lakshmi Yatham, MD, is a Professor of Psychiatry in the Department of Psychiatry at the University of British Columbia in Vancouver, Canada. He is also the Regional Head of Psychiatry and Regional Program Medical Director for Mental Health and Addictions at Vancouver Coastal Health and Providence Healthcare.  |  read more...

Image: